ArticleFrontiers in molecular neuroscience2025
Analyses of exon 4a structure reveal the properties of Big tau related to distribution, function and aggregation.
Article in Frontiers in molecular neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- The Enigma of Big Tau Exon 4a: Genomic Architecture, Biophysical Identity, and Unique Evolutionary Mechanisms.Biomolecules · 2026Review
- Promoter mutagenesis and a massively parallel reporter screen of thebioRxiv : the preprint server for biology · 2026Article
- Big Tau: Structure, Evolutionary Divergence, and Emerging Roles in Cytoskeletal Dynamics and Tauopathies.Cells · 2026Review
Corrections and comments
- Update of
Authors and funding
2 authors.
Funding
Abstract
Tau, a microtubule-associated protein that modulates the dynamic properties of microtubules, is best known for its involvement in tauopathies. Usually expressed as the low molecular (LMW) variants of 45-60 kDa, tau is also expressed as a high molecular weight isoform of 110 kDa, termed Big tau, in neurons of the peripheral nervous system and in a few types of central neurons. Big tau is defined by the inclusion of exon 4a, which adds about 250 amino acids to the projection domain. Despite low sequence conservation the length of the Big tau insert remains remarkably consistent across vertebrates. Here, we analyzed the charge distribution, hydrophobicity, and aggregation propensity of the human sequences of LMW tau, Big tau and the amino acids encoded by exon 4a. Exon 4a amino acids display a pronounced negative net charge of acidic amino acids, an overall hydrophilic composition and low β-sheet content. This contrasts with LMW tau, which is more hydrophobic with extended aggregation-prone motifs including a relatively high β-sheet content. Inclusion of exon 4a in Big tau shifts the global hydrophobicity to intermediate values and reduces predicted β-sheet content, suggesting decreased aggregation propensity. We propose a model in which inclusion of the additional stretch of amino acids encoded by exon 4a shields the aggregation motifs of LMW tau and limits their exposure, which together with its unique biophysical structure, defines the properties of Big tau, Evolutionary analyses across vertebrates (human, rat, zebra finch, frog) confirms the minimal sequence identity and conserved exon size but shows preservation of negative net charge indicating convergent retention of charge-based properties. Hydrophilicity was also broadly conserved, though less invariant across species. These results are consistent with the presence of Big tau in neurons that are resistant to tauopathies that commonly afflict neurons expressing only LMW tau.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.